Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.

Maxwell CJ, Vu M, Hogan DB, Patten SB, Jantzi M, Kergoat MJ, Jetté N, Bronskill SE, Heckman G, Hirdes JP.

Drugs Aging. 2013 Jul;30(7):569-85. doi: 10.1007/s40266-013-0083-y.

PMID:
23605786
2.

A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Buckley JS, Salpeter SR.

Drugs Aging. 2015 Jun;32(6):453-67. doi: 10.1007/s40266-015-0266-9. Review.

PMID:
25941104
3.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
4.

Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.

Delrieu J, Piau A, Caillaud C, Voisin T, Vellas B.

CNS Drugs. 2011 Mar;25(3):213-26. doi: 10.2165/11539810-000000000-00000. Review.

PMID:
21323393
5.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

6.

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.

PMID:
17060346
7.

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Tariot PN.

J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23. Review.

PMID:
16649847
8.

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.

Gauthier S, Molinuevo JL.

Alzheimers Dement. 2013 May;9(3):326-31. doi: 10.1016/j.jalz.2011.11.005. Epub 2012 Oct 27. Review.

PMID:
23110864
9.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
10.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
11.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
12.

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M.

Ann Intern Med. 2008 Mar 4;148(5):379-97. Review.

PMID:
18316756
13.

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Fioravanti M, Flicker L.

Cochrane Database Syst Rev. 2001;(4):CD003159. Review.

PMID:
11687175
14.

Treatment of Alzheimer's disease in the long-term-care setting.

Smith DA.

Am J Health Syst Pharm. 2009 May 15;66(10):899-907. doi: 10.2146/ajhp070622. Review.

PMID:
19420308
15.
16.

Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force.

Lin JS, O'Connor E, Rossom RC, Perdue LA, Eckstrom E.

Ann Intern Med. 2013 Nov 5;159(9):601-12. Review. Erratum in: Ann Intern Med. 2014 Jan 7;160(1):72.

PMID:
24145578
17.

The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.

Hindle JV.

J Neural Transm (Vienna). 2013 Apr;120(4):649-53. doi: 10.1007/s00702-013-0994-0. Epub 2013 Feb 22. Review.

PMID:
23430276
18.

Inappropriate treatments for patients with cognitive decline.

Robles Bayón A, Gude Sampedro F.

Neurologia. 2014 Nov-Dec;29(9):523-32. doi: 10.1016/j.nrl.2012.05.004. Epub 2012 Oct 9. Review. English, Spanish.

19.

Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review.

Elliott RA, Goeman D, Beanland C, Koch S.

Curr Clin Pharmacol. 2015;10(3):213-21. Review.

PMID:
26265487
20.

Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review.

Johnell K.

Curr Clin Pharmacol. 2015;10(3):178-84. Review.

PMID:
26054404
Items per page

Supplemental Content

Write to the Help Desk